Cargando…
Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET(∞)H(2)O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were m...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403338/ https://www.ncbi.nlm.nih.gov/pubmed/30842438 http://dx.doi.org/10.1038/s41598-019-39598-0 |
_version_ | 1783400576379256832 |
---|---|
author | Kodaira, Satoshi Kitamura, Hisashi Kurano, Mieko Kawashima, Hajime Benton, Eric R. |
author_facet | Kodaira, Satoshi Kitamura, Hisashi Kurano, Mieko Kawashima, Hajime Benton, Eric R. |
author_sort | Kodaira, Satoshi |
collection | PubMed |
description | The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET(∞)H(2)O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were measured using CR-39 plastic nuclear track detectors and analyzed by means of atomic force microscopy. It was found that secondary target fragments contributed 20% to dose equivalent for primary protons (157 MeV), 13% for primary helium ions (145 MeV/n) and 4% for primary carbon ions (383 MeV/n), respectively. Little research has been done on the contribution from these particles to primary given dose. The smaller contribution measured for energetic carbon ion beams compared to proton beams can be considered an advantage of carbon ion radiotherapy over proton radiotherapy. |
format | Online Article Text |
id | pubmed-6403338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64033382019-03-08 Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors Kodaira, Satoshi Kitamura, Hisashi Kurano, Mieko Kawashima, Hajime Benton, Eric R. Sci Rep Article The linear energy transfer (LET) spectrum, absorbed dose and dose equivalent from secondary particles of LET(∞)H(2)O ≥15 keV/μm deposited within the plateau of the Bragg curve in primary particle-induced nuclear target fragmentation reactions in tissue during proton and heavy ion radiotherapy were measured using CR-39 plastic nuclear track detectors and analyzed by means of atomic force microscopy. It was found that secondary target fragments contributed 20% to dose equivalent for primary protons (157 MeV), 13% for primary helium ions (145 MeV/n) and 4% for primary carbon ions (383 MeV/n), respectively. Little research has been done on the contribution from these particles to primary given dose. The smaller contribution measured for energetic carbon ion beams compared to proton beams can be considered an advantage of carbon ion radiotherapy over proton radiotherapy. Nature Publishing Group UK 2019-03-06 /pmc/articles/PMC6403338/ /pubmed/30842438 http://dx.doi.org/10.1038/s41598-019-39598-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kodaira, Satoshi Kitamura, Hisashi Kurano, Mieko Kawashima, Hajime Benton, Eric R. Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors |
title | Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors |
title_full | Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors |
title_fullStr | Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors |
title_full_unstemmed | Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors |
title_short | Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors |
title_sort | contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, he and c beams measured with cr-39 plastic nuclear track detectors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403338/ https://www.ncbi.nlm.nih.gov/pubmed/30842438 http://dx.doi.org/10.1038/s41598-019-39598-0 |
work_keys_str_mv | AT kodairasatoshi contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors AT kitamurahisashi contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors AT kuranomieko contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors AT kawashimahajime contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors AT bentonericr contributiontodoseinhealthytissuefromsecondarytargetfragmentsintherapeuticprotonheandcbeamsmeasuredwithcr39plasticnucleartrackdetectors |